Revenue cycle management has traditionally been seen as a back-office function in GCC healthcare. What structural changes in the region’s payer landscape are forcing it into the boardroom now?

The focus on the implementation of national mandatory health insurance schemes is growing across the region, and with this, healthcare providers’ revenues are undergoing a structural shift from reactive, passive reimbursements to a more engaged, sophisticated, payer-dominated market. This has ultimately driven the transformation of RCM from a back-office function to an established revenue integrity necessity, resulting in stronger strategic margins, improved cash flow, and more mature data capabilities. RCM is no longer about, “How efficiently do we submit claims?” It is becoming, “How do we protect revenue and margin under increasingly sophisticated payer rules?”

GCC health systems operate across very different regulatory and reimbursement models, from Dubai’s DHA to Saudi’s NPHIES to Qatar’s public system. How does a single AI platform stay accurate across such fragmented rule sets?

It is certainly not a one-size-fits-all approach. Before designing and implementing a localised AI platform, we focus on the correct implementation of regulatory mandates and reimbursement models across the relevant jurisdictions. We also ensure that validated data standards and governance frameworks are in place to build the right guardrails, create opportunities for innovation, and enable collaboration with the private sector, including startups.

Click here to join our WhatsApp channel here

Emerging AI capabilities are extremely important in driving innovation; however, no AI model across our platforms goes unchecked. This is why we have invested heavily in adding validation and monitoring layers. Our CareFlow and Thynk rule-based solutions act as these layers, ensuring quality outcomes and responsible deployment of AI.

Scaling a workforce from 30 to 80 in a year is a significant operational stretch. What broke first as you scaled, and how did you fix it?

Finding and recruiting the right talent across engineering and customer success verticals was one challenge; ensuring they were genuinely integrated into our vision, market dynamics, and product roadmap was another challenge entirely.

Alao read: Life-Saving Multidisciplinary Surgery Leads to Full Patient Recovery

Admittedly, it has been tough, but we understood early on the urgency and importance of redesigning our delivery model to support a distributed team. We focused on making effective use of every communication and knowledge transfer tool available, from building knowledge bases and pairing new team members with experienced resources to hosting town halls and frequent in-person leadership visits across regional markets. These initiatives helped ensure alignment, strengthen collaboration, and maintain a one-team spirit.

Long-term public sector contracts, like the Qatar engagement, involve multi-year delivery risk. What is the biggest operational risk in executing a seven-year national-scale RCM contract, and how is it mitigated?

With any multi-year, national-scale engagement, there are several risk factors at play: dynamic project scope, a large and diverse stakeholder landscape, and external market forces that cannot be fully controlled. However, if I had to identify the biggest one, it would be scope evolution over the long term. The environment in which you deliver will inevitably change, and a rigid delivery model can quickly become ineffective under that pressure.

The mitigation is not purely contractual; it is relational. The key to any sustainable, long-term engagement is operating as a true partner, with a joint mission and shared objectives for success, rather than as a vendor simply executing a fixed statement of work.

AI-assisted coding and denial prediction raise questions about accountability when the system gets something wrong. Who is ultimately responsible when an AI recommendation leads to a denied or delayed claim?

The healthcare provider remains the custodian of the medical record and the accuracy of related claims. AI can recommend a billing code, flag a denial risk, or prioritise a high-risk claim for review, but it does not assume the provider’s contractual, regulatory, or medical responsibility for the claim. At this stage, I consider AI to be a co-pilot for the user, providing workflow automation and alerts rather than acting as an autonomous agent.

The accountability is best viewed across three layers:

Provider: Accountable for the claim submitted and for maintaining appropriate human oversight, governance, and audit controls.

AI Technology: Responsible for the performance of the technology, including accuracy, transparency, model validation, data governance, security, and meeting contractual service commitments.

Payer: Responsible for applying policy coverage and reimbursement rules consistently, while providing appropriate mechanisms and clear justifications to challenge incorrect denials.

Handling clinical and billing data at this scale invites scrutiny on data residency and patient privacy. How is patient data segregated or protected across your multi-country operations?

Our approach is based on data sovereignty, segregation, and least-privilege access. Patient-level data remains within the jurisdiction required by local GCC regulations, while also adhering to international standards such as HIPAA and ISO 27001/27701, as well as client-specific privacy and confidentiality policies. Each market and client environment is logically – and where required, physically – segregated. We do not need to centralise identifiable patient data across countries to operate our RCM solutions.

Data is encrypted in transit and at rest, access is role-based and auditable, and only the minimum necessary data is exposed to authorised users and systems. Where data is used for analytics or model improvement, the principle is to use de-identified or aggregated information rather than moving identifiable clinical records across borders.

The key point is that our AI architecture must adapt to the regulatory environment – RCM and healthcare regulations continue to evolve rapidly. As we scale across the GCC, data residency, privacy, security, and data governance are therefore designed for each market, while the underlying technology remains scalable.

Looking three years out, what would success look like for Santechture beyond revenue growth, in terms of the sector’s relationship with AI in financial operations?

Success three years from now would mean that AI in healthcare financial operations is no longer treated as an experiment, but as a core RCM intelligent layer.

For Santechture, that would mean three things: first, providers trust AI to support decision-making across coding, claims, denials, and revenue optimisation, with clear human oversight. Second, the industry shifts from using AI to fix problems after they occur to preventing revenue leakage and claim denials before they happen. Third, we can demonstrate that this technology is improving the sustainability of healthcare systems – not simply by reducing administrative costs, but by enabling doctors, providers, and payers to spend less time managing financial friction and more time delivering care with well-defined value-based healthcare outcomes for patients.

The true measure of success is not how much AI Santechture deploys. It is whether, in three years, healthcare leaders across the region view intelligent financial operations as essential to running a high-performing healthcare provider and successfully navigating the value-based healthcare delivery challenge.